HAEMONETICS CORP Quarterly Amortization of Intangible Assets in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Haemonetics Corp quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2020 to Q3 2024.
  • Haemonetics Corp Amortization of Intangible Assets for the quarter ending September 28, 2024 was $14.2M, a 51.1% increase year-over-year.
  • Haemonetics Corp Amortization of Intangible Assets for the twelve months ending September 28, 2024 was $51M, a 20.8% increase year-over-year.
  • Haemonetics Corp annual Amortization of Intangible Assets for 2023 was $41.4M, a 1.66% decline from 2022.
  • Haemonetics Corp annual Amortization of Intangible Assets for 2022 was $42.1M, a 25.6% decline from 2021.
  • Haemonetics Corp annual Amortization of Intangible Assets for 2021 was $56.6M, a 37.4% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $51M $14.2M +$4.8M +51.1% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-07
Q2 2024 $46.2M $14.5M +$4.8M +49.5% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-08
Q1 2024 $41.4M $13M +$267K +2.1% Dec 31, 2023 Mar 30, 2024 10-K 2024-05-20
Q4 2023 $41.1M $9.3M -$1.1M -10.6% Oct 1, 2023 Dec 30, 2023 10-Q 2024-02-08
Q3 2023 $42.2M $9.4M -$1.2M -11.3% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $43.4M $9.7M +$1.33M +15.9% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-08
Q1 2023 $42.1M $12.7M -$7.94M -38.4% Jan 1, 2023 Apr 1, 2023 10-K 2024-05-20
Q4 2022 $50M $10.4M -$1.75M -14.4% Oct 2, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 $51.8M $10.6M -$800K -7.02% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-02
Q2 2022 $52.6M $8.37M -$4.01M -32.4% Apr 3, 2022 Jul 2, 2022 10-Q 2022-08-10
Q1 2022 $56.6M $20.7M +$3.67M +21.6% Jan 2, 2022 Apr 2, 2022 10-K 2024-05-20
Q4 2021 $52.9M $12.2M +$4.35M +55.7% Oct 3, 2021 Jan 1, 2022 10-Q 2023-02-07
Q3 2021 $48.6M $11.4M +$3.27M +40.3% Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-08
Q2 2021 $45.3M $12.4M +$4.12M +49.8% Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-10
Q1 2021 $41.2M $17M Dec 27, 2020 Apr 3, 2021 10-K 2023-05-22
Q4 2020 $7.81M Sep 27, 2020 Dec 26, 2020 10-Q 2022-02-08
Q3 2020 $8.13M Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-09
Q2 2020 $8.26M Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.